Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

EMT is the dominant program in human colon cancer.

Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw PM, Huang PS, Van't Veer L, Tollenaar RA, Jackson DB, Agrawal D, Dai H, Yeatman TJ.

BMC Med Genomics. 2011 Jan 20;4:9. doi: 10.1186/1755-8794-4-9.

2.

Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.

Qi L, Sun B, Liu Z, Cheng R, Li Y, Zhao X.

J Exp Clin Cancer Res. 2014 Dec 11;33:107. doi: 10.1186/s13046-014-0107-4.

3.

Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.

Todosi AM, Gavrilescu MM, Aniţei GM, Filip B, Scripcariu V.

Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1106-11. Review.

PMID:
23700897
4.

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.

Mak MP, Tong P, Diao L, Cardnell RJ, Gibbons DL, William WN, Skoulidis F, Parra ER, Rodriguez-Canales J, Wistuba II, Heymach JV, Weinstein JN, Coombes KR, Wang J, Byers LA.

Clin Cancer Res. 2016 Feb 1;22(3):609-20. doi: 10.1158/1078-0432.CCR-15-0876. Epub 2015 Sep 29.

5.

Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression.

Qi L, Sun B, Liu Z, Li H, Gao J, Leng X.

Cancer Sci. 2012 Apr;103(4):828-35. doi: 10.1111/j.1349-7006.2012.02222.x. Epub 2012 Feb 23.

6.

HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.

Ji M, Lee EJ, Kim KB, Kim Y, Sung R, Lee SJ, Kim DS, Park SM.

Oncol Rep. 2015 May;33(5):2299-308. doi: 10.3892/or.2015.3879. Epub 2015 Mar 23.

PMID:
25813246
7.

CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.

Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR.

Int J Oncol. 2012 Jul;41(1):211-8. doi: 10.3892/ijo.2012.1453. Epub 2012 Apr 30.

PMID:
22552741
8.

Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis.

Bhat AA, Pope JL, Smith JJ, Ahmad R, Chen X, Washington MK, Beauchamp RD, Singh AB, Dhawan P.

Oncogene. 2015 Aug 27;34(35):4570-80. doi: 10.1038/onc.2014.385. Epub 2014 Dec 15.

9.

DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

Roy N, Bommi PV, Bhat UG, Bhattacharjee S, Elangovan I, Li J, Patra KC, Kopanja D, Blunier A, Benya R, Bagchi S, Raychaudhuri P.

Cancer Res. 2013 Jun 15;73(12):3771-82. doi: 10.1158/0008-5472.CAN-12-4069. Epub 2013 Apr 22.

10.

Alcohol stimulates activation of Snail, epidermal growth factor receptor signaling, and biomarkers of epithelial-mesenchymal transition in colon and breast cancer cells.

Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A.

Alcohol Clin Exp Res. 2010 Jan;34(1):19-31. doi: 10.1111/j.1530-0277.2009.01061.x. Epub 2009 Oct 23.

11.

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR, Goel A.

Gut. 2013 Sep;62(9):1315-26. doi: 10.1136/gutjnl-2011-301846. Epub 2012 Jun 26.

12.

HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.

Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T.

Cancer Lett. 2014 Dec 1;355(1):130-40. doi: 10.1016/j.canlet.2014.09.007. Epub 2014 Sep 11.

PMID:
25218351
13.

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.

Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D, Ayadi M, Kirzin S, Chazal M, Fléjou JF, Benchimol D, Berger A, Lagarde A, Pencreach E, Piard F, Elias D, Parc Y, Olschwang S, Milano G, Laurent-Puig P, Boige V.

PLoS Med. 2013;10(5):e1001453. doi: 10.1371/journal.pmed.1001453. Epub 2013 May 21.

14.

Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.

Herrera M, Islam AB, Herrera A, Martín P, García V, Silva J, Garcia JM, Salas C, Casal I, de Herreros AG, Bonilla F, Peña C.

Clin Cancer Res. 2013 Nov 1;19(21):5914-26. doi: 10.1158/1078-0432.CCR-13-0694. Epub 2013 Sep 19.

15.

MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.

Tian Y, Pan Q, Shang Y, Zhu R, Ye J, Liu Y, Zhong X, Li S, He Y, Chen L, Zhao J, Chen W, Peng Z, Wang R.

J Biol Chem. 2014 Dec 26;289(52):36101-15. doi: 10.1074/jbc.M114.598383. Epub 2014 Nov 4.

16.

Epithelial-mesenchymal transition associates with maintenance of stemness in spheroid-derived stem-like colon cancer cells.

Han XY, Wei B, Fang JF, Zhang S, Zhang FC, Zhang HB, Lan TY, Lu HQ, Wei HB.

PLoS One. 2013 Sep 9;8(9):e73341. doi: 10.1371/journal.pone.0073341. eCollection 2013.

17.

Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.

Lu MH, Huang CC, Pan MR, Chen HH, Hung WC.

Clin Cancer Res. 2012 Dec 1;18(23):6416-25. doi: 10.1158/1078-0432.CCR-12-0832. Epub 2012 Oct 8.

18.

Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells.

Andreolas C, Kalogeropoulou M, Voulgari A, Pintzas A.

Int J Cancer. 2008 Apr 15;122(8):1745-56.

19.

Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell lines.

Okajima M, Kokura S, Ishikawa T, Mizushima K, Tsuchiya R, Matsuyama T, Adachi S, Okayama T, Sakamoto N, Kamada K, Katada K, Uchiyama K, Handa O, Takagi T, Yagi N, Naito Y, Yoshikawa T.

Oncol Rep. 2013 Jun;29(6):2311-7. doi: 10.3892/or.2013.2401. Epub 2013 Apr 10.

PMID:
23589103
20.

Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.

Kim JH, Hwang YJ, Han SH, Lee YE, Kim S, Kim YJ, Cho JH, Kwon KA, Kim JH, Kim SH.

World J Gastroenterol. 2015 Sep 14;21(34):9887-99. doi: 10.3748/wjg.v21.i34.9887.

Supplemental Content

Support Center